Silo Pharma, Inc. (SILO)

Silo Pharma Statistics

Total Valuation

Silo Pharma has a market cap or net worth of $5.20 million. The enterprise value is -$668,084.

Market Cap	5.20M
Enterprise Value	-668,084

Important Dates

The last earnings date was Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Silo Pharma has 13.32 million shares outstanding. The number of shares has increased by 87.67% in one year.

Current Share Class	13.32M
Shares Outstanding	13.32M
Shares Change (YoY)	+87.67%
Shares Change (QoQ)	+48.59%
Owned by Insiders (%)	10.20%
Owned by Institutions (%)	4.49%
Float	10.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	33.35
Forward PS	n/a
PB Ratio	0.82
P/TBV Ratio	1.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.70

Current Ratio	8.70
Quick Ratio	8.29
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,088.94

Financial Efficiency

Return on equity (ROE) is -86.11% and return on invested capital (ROIC) is -56.27%.

Return on Equity (ROE)	-86.11%
Return on Assets (ROA)	-44.37%
Return on Invested Capital (ROIC)	-56.27%
Return on Capital Employed (ROCE)	-93.50%
Revenue Per Employee	$24,034
Profits Per Employee	-$1.69M
Employee Count	3
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.70% in the last 52 weeks. The beta is 0.63, so Silo Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	-58.70%
50-Day Moving Average	0.59
200-Day Moving Average	0.80
Relative Strength Index (RSI)	31.34
Average Volume (20 Days)	297,196

Short Selling Information

The latest short interest is 67,438, so 0.51% of the outstanding shares have been sold short.

Short Interest	67,438
Short Previous Month	134,766
Short % of Shares Out	0.51%
Short % of Float	0.65%
Short Ratio (days to cover)	0.70

Income Statement

In the last 12 months, Silo Pharma had revenue of $72,102 and -$5.08 million in losses. Loss per share was -$0.82.

Revenue	72,102
Gross Profit	47,036
Operating Income	-5.31M
Pretax Income	-5.08M
Net Income	-5.08M
EBITDA	-5.30M
EBIT	-5.31M
Loss Per Share	-$0.82

Balance Sheet

The company has $5.87 million in cash and n/a in debt, giving a net cash position of $5.87 million or $0.44 per share.

Cash & Cash Equivalents	5.87M
Total Debt	n/a
Net Cash	5.87M
Net Cash Per Share	$0.44
Equity (Book Value)	5.01M
Book Value Per Share	0.48
Working Capital	5.46M

Cash Flow

Operating Cash Flow	-4.80M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	65.24%
Operating Margin	-7,361.09%
Pretax Margin	-7,041.12%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Silo Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-87.67%
Shareholder Yield	-87.67%
Earnings Yield	-97.67%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 15, 2022. It was a reverse split with a ratio of 1:50.

Last Split Date	Sep 15, 2022
Split Type	Reverse
Split Ratio	1:50

Scores

Silo Pharma has an Altman Z-Score of -3.48 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.48
Piotroski F-Score	3